Eiko LifeSciences Limited (BOM:540204)
48.67
-1.09 (-2.19%)
At close: Oct 1, 2026
Eiko LifeSciences Revenue
Eiko LifeSciences had revenue of 167.49M INR in the quarter ending June 30, 2026, with 56.36% growth. This brings the company's revenue in the last twelve months to 587.44M, up 56.13% year-over-year. In the fiscal year ending March 31, 2026, Eiko LifeSciences had annual revenue of 525.71M with 39.58% growth.
Revenue (ttm)
587.44M
Revenue Growth
+56.13%
P/S Ratio
1.19
Revenue / Employee
83.92M
Employees
7
Market Cap
698.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 525.71M | 149.07M | 39.58% |
| Mar 31, 2025 | 376.64M | 97.35M | 34.86% |
| Mar 31, 2024 | 279.29M | 96.08M | 52.44% |
| Mar 31, 2023 | 183.21M | -70.91M | -27.90% |
| Mar 31, 2022 | 254.12M | 134.21M | 111.93% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Virat Crane Industries | 1.82B |
| New Swan Multitech | 1.77B |
| Accel | 1.69B |
| Filtra Consultants and Engineers | 976.77M |
| Kasturi Metal Composite | 643.69M |
| RR Financial Consultants | 311.08M |
| Shree Pacetronix | 211.91M |
| Identixweb | 130.47M |